BTEK.L vs. XDWH.L
BTEK.L (iShares Nasdaq US Biotechnology UCITS ETF) and XDWH.L (Xtrackers MSCI World Health Care UCITS ETF 1C) are both Health & Biotech Equities funds - BTEK.L tracks the NASDAQ Biotechnology TR USD while XDWH.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, BTEK.L returned 5.85%/yr vs 5.67%/yr for XDWH.L. A 0.68 correlation means they provide meaningful diversification when combined. BTEK.L charges 0.35%/yr vs 0.25%/yr for XDWH.L.
Performance
BTEK.L vs. XDWH.L - Performance Comparison
Loading charts...
Different Trading Currencies
BTEK.L is traded in GBP, while XDWH.L is traded in USD. To make them comparable, the XDWH.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, BTEK.L achieves a 4.86% return, which is significantly higher than XDWH.L's -2.35% return.
BTEK.L
- 1D
- 3.56%
- 1M
- 2.25%
- YTD
- 4.86%
- 6M
- 2.70%
- 1Y
- 43.15%
- 3Y*
- 10.19%
- 5Y*
- 5.85%
- 10Y*
- —
XDWH.L
- 1D
- 2.99%
- 1M
- 4.20%
- YTD
- -2.35%
- 6M
- -2.32%
- 1Y
- 12.65%
- 3Y*
- 2.85%
- 5Y*
- 5.67%
- 10Y*
- 8.66%
BTEK.L vs. XDWH.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 23.81% | -0.32% | 0.33% | -1.55% | 0.90% | 23.11% | 21.63% | -6.34% | -3.31% |
XDWH.L Xtrackers MSCI World Health Care UCITS ETF 1C | -2.35% | 7.04% | 2.51% | -1.38% | 5.83% | 21.71% | 9.57% | 18.28% | 7.59% | -2.05% |
Correlation
The correlation between BTEK.L and XDWH.L is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2017 | 0.68 |
The correlation between BTEK.L and XDWH.L has been stable across timeframes, ranging from 0.63 to 0.69 - a consistent structural relationship.
BTEK.L vs. XDWH.L - Sectors Allocation Comparison
Sectors
BTEK.L
XDWH.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BTEK.L
XDWH.L
Basic Materials
BTEK.L
-
XDWH.L
-
Communication Services
BTEK.L
-
XDWH.L
-
Consumer Cyclical
BTEK.L
-
XDWH.L
-
Consumer Defensive
BTEK.L
-
XDWH.L
Energy
BTEK.L
-
XDWH.L
-
Financial Services
BTEK.L
-
XDWH.L
-
Industrials
BTEK.L
-
XDWH.L
-
Real Estate
BTEK.L
-
XDWH.L
-
Technology
BTEK.L
-
XDWH.L
-
Utilities
BTEK.L
-
XDWH.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEK.L vs. XDWH.L — Risk / Return Rank
BTEK.L
XDWH.L
BTEK.L vs. XDWH.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Xtrackers MSCI World Health Care UCITS ETF 1C (XDWH.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BTEK.L | XDWH.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.38 | ||
| Sortino ratioReturn per unit of downside risk | +1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.16 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 6.23 | 1.21 | +5.02 |
| Martin ratioReturn relative to average drawdown | 17.55 | 3.15 | +14.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BTEK.L | XDWH.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.24 | 0.86 | +1.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | 0.40 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.56 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.59 | -0.28 |
Drawdowns
BTEK.L vs. XDWH.L - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, which is greater than XDWH.L's maximum drawdown of -18.80%. Use the drawdown chart below to compare losses from any high point for BTEK.L and XDWH.L.
Loading charts...
Drawdown Indicators
| BTEK.L | XDWH.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.86% | -18.80% | -12.06% |
Max Drawdown (1Y)Largest decline over 1 year | -6.89% | -10.43% | +3.54% |
Max Drawdown (3Y)Largest decline over 3 years | -26.34% | -18.80% | -7.54% |
Max Drawdown (5Y)Largest decline over 5 years | -30.86% | -18.80% | -12.06% |
Max Drawdown (10Y)Largest decline over 10 years | — | -18.80% | — |
Current DrawdownCurrent decline from peak | -1.86% | -5.80% | +3.94% |
Average DrawdownAverage peak-to-trough decline | -10.04% | -4.41% | -5.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.45% | 4.01% | -1.56% |
Volatility
BTEK.L vs. XDWH.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a higher volatility of 6.91% compared to Xtrackers MSCI World Health Care UCITS ETF 1C (XDWH.L) at 5.30%. This indicates that BTEK.L's price experiences larger fluctuations and is considered to be riskier than XDWH.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEK.L | XDWH.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.91% | 5.30% | +1.61% |
Volatility (6M)Calculated over the trailing 6-month period | 14.67% | 10.98% | +3.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.14% | 14.58% | +4.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.08% | 14.02% | +6.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.71% | 15.50% | +6.21% |
BTEK.L vs. XDWH.L - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is higher than XDWH.L's 0.25% expense ratio.
Dividends
BTEK.L vs. XDWH.L - Dividend Comparison
Neither BTEK.L nor XDWH.L has paid dividends to shareholders.
Frequently Asked Questions
BTEK.L and XDWH.L have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XDWH.L is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XDWH.L is cheaper with a 0.25% expense ratio, compared with 0.35% for BTEK.L.
BTEK.L tracks NASDAQ Biotechnology TR USD, while XDWH.L tracks MSCI World/Health Care NR USD. They also come from different issuers: iShares and Xtrackers. Their fees differ too: 0.35% for BTEK.L and 0.25% for XDWH.L.
Find the right allocation for BTEK.L and XDWH.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer